Education
About Us
Working with TipRanks
Follow Us
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD)
ASX:RMD
Earnings Data
Report Date
Oct 23, 2025After Close (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
0.38Last Year’s EPS
0.33Same Quarter Last Year
Strong Buy
Based on 10 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlights strong financial performance with notable revenue growth, gross margin expansion, and significant shareholder returns. ResMed emphasizes ongoing innovation and strategic acquisitions, but faces uncertainties in competitive bidding and market competition. Overall, the positives significantly outweigh the negatives.Company Guidance
Strong Revenue Growth
ResMed achieved 10% year-over-year reported revenue growth and 9% in constant currency terms, reflecting positive contributions across product and ReSupply portfolio.
Gross Margin Expansion
The company reported a 230 basis points year-over-year gross margin expansion and 150 basis points sequentially, driven by procurement, manufacturing and logistics efficiencies, as well as favorable foreign currency movements.
Free Cash Flow and Shareholder Returns
ResMed's fiscal year 2025 free cash flow was $1.7 billion, allowing significant flexibility for business investments and capital returns to shareholders, including over $610 million in dividends and share repurchases.
Dividend Increase and Share Repurchase Program
The Board of Directors authorized a 13% increase in the quarterly dividend for fiscal year 2026 and plans to increase share buyback program, purchasing shares to the value of approximately $150 million per quarter.
Innovation and Product Development
ResMed continues to innovate with the rollout of AI and GenAI technologies into digital products and plans for a wider rollout of the Dawn digital assistant across the myAir platform throughout fiscal year 2026.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) Earnings, Revenues Date & History
AU:RMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
AU:RMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Jul 31, 2025 | AU$42.36 | AU$42.79 | +1.02% |
Apr 23, 2025 | AU$33.11 | AU$35.92 | +8.49% |
Jan 30, 2025 | AU$40.24 | AU$39.92 | -0.80% |
Oct 24, 2024 | AU$35.31 | AU$37.40 | +5.92% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) report earnings?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) is schdueled to report earning on Oct 23, 2025, After Close (Confirmed).
What is Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) earnings time?
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) earnings time is at Oct 23, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock?
The P/E ratio of Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh is N/A.
What is AU:RMD EPS forecast?
AU:RMD EPS forecast for the fiscal quarter 2026 (Q1) is 0.38.